Pfizer Inc. buy Guggenheim
Start price
17.12.25
/
50%
€21.74
Target price
17.12.26
-
Performance (%)
4.07%
Price
20.02.26
€22.63
Summary
This prediction is currently active. With a performance of 4.07%, the BUY prediction by Guggenheim for Pfizer Inc. is trending in the right direction. This prediction currently runs until 17.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | -2.541% | -2.541% |
| iShares Core DAX® | 1,43 % | 2,63 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % |
| iShares S&P 500 | 1,92 % | 1,16 % |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (NYSE:PFE) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat